Form4insider filings, from the source

SEC Form 4 · accession 0001636178-26-000027

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
James Edgemond
Officer — CFO AND TREASURER
Period of report
Jun 15, 2026
Accepted (ET)
Jun 16, 2026 · 4:35 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 15, 2026M10,000$117.76A28,876D
Common StockF2Jun 15, 2026S121$538.5233D28,755D
Common StockF3Jun 15, 2026S74$539.4576D28,681D
Common StockF4Jun 15, 2026S45$540.638D28,636D
Common StockF5Jun 15, 2026S240$541.6117D28,396D
Common StockF6Jun 15, 2026S560$543.5046D27,836D
Common StockF7Jun 15, 2026S855$545.6344D26,981D
Common StockF8Jun 15, 2026S504$546.5354D26,477D
Common StockF9Jun 15, 2026S465$547.7661D26,012D
Common StockF10Jun 15, 2026S1,616$548.6391D24,396D
Common StockF11Jun 15, 2026S800$549.8704D23,596D
Common StockF12Jun 15, 2026S2,200$550.8909D21,396D
Common StockF13Jun 15, 2026S1,144$551.9074D20,252D
Common StockF14Jun 15, 2026S778$553.0989D19,474D
Common StockF15Jun 15, 2026S598$553.7629D18,876D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option$117.76Jun 15, 2026M10,000DMar 15, 2023Mar 15, 2027Common Stock10,0000D

Explanation of responses